Impact of routine screening and preemptive treatment on hepatitis B virus reactivation (HBVr) in patients receiving chemotherapy

被引：0
|
作者：
Marty, C. [1 ]
Martel, D. [2 ]
Martel-Lafernere, V. [3 ]
Doucet, S. [4 ]
Ceballos, P. [5 ]
Adam, J-P. [2 ]
机构：
[1] Aix Marseille Univ, Fac Pharm, Marseille, France
[2] CHUM, Pharm, Montreal, PQ, Canada
[3] CHUM, Microbiol & Infect Dis, Montreal, PQ, Canada
[4] CHUM, Med Oncol Hematol, Montreal, PQ, Canada
[5] Ctr Hosp Univ St Eloi, Clin Hematol, Montpellier, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1837P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Acute hepatitis and reactivation of hepatitis C virus in cancer patients receiving systemic chemotherapy
    Lee, Hae Lim
    Bae, Si Hyun
    Yang, Hyun
    Jang, Jeong Won
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2015, 62 : 1127A - 1127A
  • [32] The treatment of severe hepatitis B virus reactivation after chemotherapy
    Li, Xing
    Xing, Yan-Fang
    Lin, Qu
    Dong, Min
    Wan, Xiang-Bo
    Wu, Xiang-Yuan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 350 - 350
  • [33] Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
    Lubel, John S.
    Angus, Peter W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 864 - 871
  • [34] Hepatitis B Reactivation in Patients Receiving Chemotherapy for Lymphoma or Breast Cancer
    Saumoy, Monica
    Schneider, Yecheskel
    Schwartz, Robert
    Kumar, Sonal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S907 - S907
  • [35] Impact of a Screening Initiative to Prevent Hepatitis B Reactivation Among Patients Receiving Rituximab.
    Minhas, Hadi Jamshaid
    Goldstein, Yitzchak D.
    Bellin, Eran
    Packer, Stuart
    Zyloney, Patricia
    Schwartz, Jonathan M.
    HEPATOLOGY, 2018, 68 : 1204A - 1204A
  • [36] Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy
    Edith Y. Ho
    Thomas Yau
    Franck Rousseau
    E. Jenny Heathcote
    George K. K. Lau
    Hepatology International, 2015, 9 : 224 - 230
  • [37] Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy
    Ho, Edith Y.
    Yau, Thomas
    Rousseau, Franck
    Heathcote, E. Jenny
    Lau, George K. K.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (02) : 224 - 230
  • [38] Hepatitis C Virus Screening in Patients With Cancer Receiving Chemotherapy
    Hwang, Jessica P.
    Suarez-Almazor, Maria E.
    Torres, Harrys A.
    Palla, Shana L.
    Huang, Donna S.
    Fisch, Michael J.
    Lok, Anna S. F.
    JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (03) : E167 - E174
  • [39] HEPATITIS B VIRUS REACTIVATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Deepan, Natee
    Chaiteerakij, Roongruedee
    Decharatanachart, Pakanat
    Maung, Soe Thiha
    GASTROENTEROLOGY, 2024, 166 (05) : S1596 - S1597
  • [40] Hepatitis C virus (HCV) infection is a protective factor for hepatitis B virus reactivation (HBVR) after receiving hepatitis B core positive (HBCAB+) donors for liver transplantation (LT)
    Orrego, Mauricio
    Restrepo, Ricardo
    Aguilar, Barbara
    Araya, Victor
    Rothstein, Kenneth D.
    Manzarbeitia, Cosme
    Reich, David J.
    Munoz, Santiago
    HEPATOLOGY, 2007, 46 (04) : 474A - 474A
12345